7.45
2.10%
-0.16
Astria Therapeutics Inc Stock (ATXS) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
29.38%
24.15
|
34.20 | 20.24 | 15.10 | 13.49 |
Operating Income/Loss |
29.38%
-24.15
|
-34.20 | -20.24 | -15.10 | -13.49 |
Nonoperating Income/Loss |
51.38%
4.222
|
2.789 | 2.509 | 2.536 | 2.305 |
Income/Loss From Continuing Operations Before Tax |
36.56%
-19.93
|
-31.41 | -17.73 | -12.57 | -11.19 |
Income/Loss From Continuing Operations After Tax |
36.56%
-19.93
|
-31.41 | -17.73 | -12.57 | -11.19 |
Net Income/Loss
|
36.56%
-19.93
|
-31.41 | -17.73 | -12.57 | -11.19 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,366%
52.29
|
2.1207 | 28.04 | 28.02 | 27.94 |
Diluted Average Shares |
2,366%
52.29
|
2.1207 | 28.04 | 28.02 | 27.94 |
Basic Earnings Per Share |
59.57%
-0.38
|
-0.94 | -0.63 | -0.45 | -0.40 |
Diluted Earnings Per Share |
59.57%
-0.38
|
-0.94 | -0.63 | -0.45 | -0.40 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):